檢索結果 - John Mumm
- Showing 1 - 1 results of 1
-
1
755 DEKA-1 a dose-finding Phase 1 trial: observing safety and biomarkers using DK210 (EGFR) for inoperable locally advanced and/or metastatic EGFR+ tumors failing systemic therapy... 由 Aurélien Marabelle, John Mumm, Douglas Orr, Alexander I Spira, Elizabeth C Moser, Deb Kientop
發表在 Journal for ImmunoTherapy of Cancer (2023-11-01)Article